Business Context and Reporting Period
This Form 8-K Current Report was filed by Becton, Dickinson and Company (BD) on November 28, 2011. The filing addresses a corporate governance event regarding the appointment of a senior officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the election of Suketu Upadhyay as Senior Vice President and Controller, effective November 28, 2011. Mr. Upadhyay succeeds William A. Tozzi, who has assumed another position within the company. Mr. Upadhyay will serve as BD's principal accounting officer.
Management Commentary and Risks
Management highlights Mr. Upadhyay's background, noting his tenure as Vice President of Finance – International since August 2010. Prior to joining BD, he served as Global Head of R&D Finance at AstraZeneca and Head of Finance for Centocor, Inc. (a former Johnson & Johnson subsidiary). The filing does not disclose specific risks, contingencies, or unusual items beyond the standard personnel transition.
Investor Verification Checklist
- Confirm the effective date of Suketu Upadhyay's appointment as Senior Vice President and Controller.
- Verify the departure status of William A. Tozzi and his new role within BD.
- Review Mr. Upadhyay's prior experience at AstraZeneca and Centocor, Inc. for relevant industry expertise.
- Note that this filing contains no financial results; refer to the most recent 10-Q or 10-K for financial metrics.